Transfusion Medicine Reviews
Volume 22, Issue 3 , Pages 202-214 , July 2008

Blood Donation and Blood Transfusion: Special Considerations for African Americans

References 

  1. Hillyer CD, Silberstein LE, Ness PM, et al. Blood banking and transfusion medicine: Basic principles & practice. (ed 2). Philadelphia: Churchill Livingstone; 2007;
  2. Sullivan MT, Cotten R, Read EJ, et al. Blood collection and transfusion in the United States in 2001. Transfusion. 2007;47:385–394
  3. Mathew SM, King MR, Glynn SA, et al. Opinions about donating blood among those who never gave and those who stopped: A focus group assessment. Transfusion. 2007;47:729–735
  4. Riley W, Schwei M, McCullough J. The Unites States' potential blood donor pool: Estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion. 2007;47:1180–1188
  5. Price CL, Boyd JH, Watkins AR, et al. Mailing of a sickle cell disease educational packet increases blood donors within an African American community. Transfusion. 2006;46:1388–1393
  6. McCarthy M. Number of cancer deaths continues to fall in USA. Lancet. 2007;369:263
  7. Moran A, Diez Roux AV, Jackson SA, et al. Acculturation is associated with hypertension in a multiethnic sample. Am J Hypertens. 2007;20:354–363
  8. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics—2007 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2007;115:e69–e171
  9. Brancati FL, Kao WHL, Folsom AR, et al. Incident type 2 diabetes mellitus in African American and White adults: The Atherosclerosis Risk in Communities Study. JAMA. 2000;283:2253–2259
  10. Powe NR. To have and have not: Health and health care disparities in chronic kidney disease. Kidney Int. 2003;64:763–772
  11. Racial/ethnic disparities in diagnoses of HIV/AIDS—33 states, 2001-2005. MMWR. 2007;56:189–193
  12. Robins EB, Blum S. Hematologic reference values for African American children and adolescents. Am J Hematol. 2006;82:611–614
  13. McClung JP, Marchitelli LJ, Friedl KE, et al. Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. J Am Coll Nutr. 2006;25:64–69
  14. Sebok MA, Notari EP, Chambers LA, et al. Seasonal temperature variation and the rate of donor deferral for low hematocrit in the American Red Cross. Transfusion. 2007;47:890–894
  15. Hoekstra T, Veldhuizen I, van Noord PAH, et al. Seasonal influences on hemoglobin levels and deferral rates in whole-blood and plasma donors. Transfusion. 2007;47:895–900
  16. Cristina V, Beato MD. Progress review: Medical product safety. Washington, DC: U.S. Department of Health and Human Services, Public Health Service; 2003;
  17. Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA. 2000;284:229–235
  18. America's Blood Centers , Vanguard Comm . Blood donation among African Americans and Hispanics: Background, hypotheses, research questions. Multicultural donor recruitment and marketing plan: Phases I.1 secondary research report. 2006;Chicago, Blackstone
  19. Gillespie TW, Hillyer CD. Blood donors and factors impacting the blood donation decision. Transfus Med Rev. 2002;16:115–130
  20. Oswalt RM. A review of blood donor motivation and recruitment. Transfusion. 1977;17:123–135
  21. London P, Hemphill BM. The motivations of blood donors. Transfusion. 1965;5:559–568
  22. Wu Y, Glynn SA, Schreiber GB, et al. First-time blood donors: Demographic trends. Transfusion. 2001;41:360–364
  23. Wang B, Schreiber GB, Glynn SA, et al. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?. Transfusion. 2005;45:1089–1096
  24. Damesyn MA, Glynn SA, Schreiber GB, et al. Behavioral and infectious disease risks in young blood donors: Implications for recruitment. Transfusion. 2003;43:1596–1603
  25. Schreiber GB, Sharma UK, Wright DJ, et al. First year donation patterns predict long-term commitment for first-time donors. Vox Sang. 2005;88:114–121
  26. Ownby HE, Kong F, Watanabe K, et al. Analysis of donor return behavior. Transfusion. 1999;39:1128–1135
  27. Glynn SA, Busch MP, Schreiber GB, et al. Effect of a national disaster on blood supply and safety. JAMA. 2003;289:2246–2253
  28. Glynn SA, Kleinman SH, Schreiber GB, et al. Motivations to donate blood: Demographic comparisons. Transfusion. 2002;42:216–225
  29. Schreiber GB, Schlumpf KS, Glynn SA, et al. Convenience, the bane of our existence, and other barriers to donating. Transfusion. 2006;46:545–553
  30. Popovsky MA. Understanding the donor can correct the nation's blood imbalance. Transfusion. 2006;46:501–502
  31. Boulware LE, Ratner LE, Ness PM, et al. The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion. 2002;42:669–678
  32. Grossman B, Watkins AR, Fleming F, et al. Barriers and motivators to blood and cord blood donations in young African-American Women. Am J Hematol. 2005;78:198–202
  33. Schoenborn CA, Marsh SL, Hardy AM. AIDS knowledge and attitudes for 1992. Data from the National Health Interview Survey. Adv Data. 1994;243:1–16
  34. Leibrecht BC, Hogan JM, Luz GA, et al. Donor and nondonor motivations. Transfusion. 1976;16:182–189
  35. Hupfer ME, Taylor DW, Letwin JA. Understanding Canadian student motivations and beliefs about giving blood. Transfusion. 2005;45:149–161
  36. Alessandrin M. Community volunteerism and blood donation: Altruism as a lifestyle choice. Transfus Med Rev. 2007;21:301–316
  37. Saguaro Seminar: Civic Engagement in America. A project of the John F. Kennedy School of Government at Harvard University. Social Capital Community Benchmark Survey Executive Summary, 2000
  38. Smith LA, Oyeku SO, Homer C, et al. A question of equity and quality. Pediatrics. 2006;117:1763–1770
  39. Josephson CD, Su LL, Hillyer KL, et al. Transfusion in the patient with sickle cell disease: A critical review of the literature and transfusion guidelines. Transfus Med Rev. 2007;21:118–133
  40. Aygun B, Padmanabhan S, Paley C, et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42:37–43
  41. Hillyer KL, Hare VW, Josephson CD, et al. Partners for life: The transfusion program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia. Immunohematol. 2006;22:108–111
  42. AABB . Technical manual. ed 14. Bethesda: AABB; 2002;
  43. Sosler SD, Jilly BJ, Saporito C, et al. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol. 1993;43:103–106
  44. Vichinsky EP, Luban NLC, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial. Transfusion. 2001;41:1086–1092
  45. Krailadsiri P, Gilcher R, Seghatchian J. Leukoreduction of sickle cell trait blood: An unresolved issue. Transfus Apher Sci. 2001;24:223–225
  46. Schuetz AN, Hillyer KL, Roback JD, et al. Leukoreduction filtration of blood with sickle cell trait. Transfus Med Rev. 2004;18:168–176
  47. Stroncek DF, Rainer T, Sharon V, et al. Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration. Transfusion. 2002;42:1466–1472
  48. Stroncek DF, Byrne KM, Noguchi CT, et al. Increasing hemoglobin oxygen saturation levels in sickle trait donor whole blood prevents hemoglobin S polymerization and allows effective white blood cell reduction by filtration. Transfusion. 2004;44:1293–1299
  49. Kelleher JF, Luban NL. Transfusion of frozen erythrocytes from a donor with sickle trait. Transfusion. 1984;24:167–168
  50. Meryman HT, Hornblower M. Freezing and deglycerolizing sickle-trait red blood cells. Transfusion. 1976;16:627–632
  51. Kochman SA. Role of the Food and Drug Administration in the use of molecular techniques in immunohematology. Transfusion. 2007;47:3S–9S
  52. Reid ME. Overview of molecular methods in immunohematology. Transfusion. 2007;47:10S–16S
  53. Press CE, Ivansco LK, Hillyer CD. Public attitudes and perceptions about the safety of the United States blood supply: Results of a large US survey. Blood. 2003;102:818a;(abstr)
  54. Ould amar AK. Red blood cells from donors with sickle cell trait: A safety issue for transfusion?. Transfus Med. 2006;16:248–253
  55. Sarode R, Altuntas F. Blood bank issues associated with red cell exchanges in sickle cell disease. J Clin Apher. 2006;21:271–273
  56. AABB . Standards for blood banks and transfusion services. ed 24. Bethesda, MD: AABB; 2006;
  57. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322:1617–1621
  58. Win N, Doughty H, Telfer P, et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion. 2001;41:323–328
  59. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37:382–392
  60. Darabi K, Dzik S. Hyperhemolysis syndrome in anemia of chronic disease. Transfusion. 2005;45:1930–1933
  61. Hendrickson JE, Chadwick TE, Roback JD, et al. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood. 2007;110:2736–2743
  62. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfusion red blood cells. Transfusion. 2006;46:1526–1536
  63. Yu J, Heck S, Yazdanbakhsh K. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol. 2007;82:691–696
  64. Okpala I. The intriguing contribution of white blood cells to sickle cell disease—A red cell disorder. Blood Rev. 2004;18:65–73
  65. Avent ND. Large scale blood group genotyping. Transfus Clin Biol. 2007;14:10–15
  66. Lau FY, Wong R, Chan NP, et al. Provision of phenotype-matched blood units: No need for pre-transfusion antibody screening. Haematologica. 2001;86:742–748
  67. Castilho L, Rios M, Bianco C, et al. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Transfusion. 2002;42:232–238
  68. National Institutes of Health , National Heart, Lung, and Blood Institute . Management of sickle cell disease. ed 4. Washington: National Institutes of Health; 2002;NIH publication 02-2117 http://www.nhlbi.nih.gov/health/prof/blood/sickle/sc_mngt.pdf
  69. Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion. 1994;34:562–569
  70. Afenyi-Annan A, Bandarenko N. Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematol. 2006;22:103–107
  71. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood. 2004;104:2263–2268
  72. Anderson SA, Menis M, O'Connell K, et al. Blood use by inpatient elderly population in the United States. Transfusion. 2007;47:582–592
  73. Lee MT, Piomelli S, Granger S, et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): Extended follow-up and final results. Blood. 2006;108:847–852
  74. Machado RF. Nitric oxide-based therapies in sickle cell disease: The evidence continues to mount. Crit Care Med. 2007;35:654–655
  75. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21:37–47
  76. Lezcano NE, Odo N, Kutlar A, et al. Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke. 2006;37:1424–1426
  77. Weiner DL, Hibberd PL, Betis P, et al. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA. 2003;289:1136–1142
  78. Machado RF, Martyr S, Kato GJ, et al. Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol. 2005;130:445–453
  79. Pawloski JR, Stamler JS. Nitric oxide in RBCs. Transfusion. 2002;42:1603–1609
  80. Dzik S. Nitric oxide: Nature's third respiratory gas. Transfusion. 2002;42:1532–1533

PII: S0887-7963(08)00014-X

doi: 10.1016/j.tmrv.2008.02.006

Transfusion Medicine Reviews
Volume 22, Issue 3 , Pages 202-214 , July 2008

Article Tools